Klinische Neurophysiologie 2011; 42(1): 1-7
DOI: 10.1055/s-0030-1266066
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Chronische Immunneuropathien – Klinisches Spektrum, Diagnostik, Therapie

Chronic Immune-Mediated Neuropathies – Clinical Finding, Diagnosis, TherapyJ.  Bufler
Further Information

Publication History

Publication Date:
04 March 2011 (online)

Lernziele

Kenntnisse über

Diagnose, Differenzialdiagnose und Therapie der chronisch inflammatorischen demyelinisierenden Polyneuropathie Diagnose, Differenzialdiagnose und Therapie der multifokalen motorischen Neuropathie

Literatur

  • 1 Dyck P J, Lais A C, Ohta M et al. Chronic inflammatory polyradiculoneuropathy.  Mayo Clin Proc. 1975;  50 621-637
  • 2 Saperstein D S, Katz J S, Amato A A et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies.  Muscle Nerve. 2001;  24 311-324
  • 3 Van den Bergh P YK, Hadden R DM, Bouche P et al. European Federation of Neurological Societies / Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision.  Europ J Neurol. 2010;  17 356-363
  • 4 Saperstein D S, Barohn R J. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.  Curr Neurol Neurosci Reports. 2003;  3 57-63
  • 5 McLeod J G, Pollard J D, Macaskill P et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia.  Ann Neurol. 1999;  46 910-913
  • 6 http://www.dgn.org/component/content/article/18-leitlinien/451-leitlinien-der-dgn-diagnostik-bei-polyneuropathien.html?q=cidp
  • 7 Mehndiratta M M, Hughes R AC. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.  Cochrane Database Syst Rev. 2002;  3 CD002062
  • 8 Lozeron P, Nahum L, Lacroix C et al. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients.  J Neurol. 2002;  249 569-575
  • 9 Roth G, Rohr J, Magistris M R et al. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia.  Eur Neurol. 1988;  25 416-423
  • 10 Parry G L, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease.  Muscle Nerve. 1988;  11 103-107
  • 11 Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies.  Muscle Nerve. 2005;  31 663-680
  • 12 Meuth S G, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options.  Eur Neurol. 2010;  63 193-204
  • 13 Katz J S, Wolfe G I, Bryan W W et al. Electrophysiologic findings in multifocal motor neuropathy.  Neurology. 1997;  48 700-707
  • 14 Joint Task Force of the EFNS and the PNS.  J Periph Nerv Syst. 2006;  11 9-19
  • 15 Olney R K. Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block.  Muscle Nerve. 1999;  8 S225-S229
  • 16 Umapathi T, Hughes R A, Nobile-Orazio E et al. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.  Cochrane Database Syst Rev. 2009;  CD003217

Johannes Bufler

Neurologische Klinik mit klinischer Neurophysiologie, Inn Salzach Klinikum Wasserburg

Postfach 1111

83501 Wasserburg

Email: Johannes.Bufler@iskl.de

    >